{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:49:53Z","timestamp":1792014593351,"version":"4.4.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T00:00:00Z","timestamp":1467158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T00:00:00Z","timestamp":1467158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["TA3048_A_1"],"award-info":[{"award-number":["TA3048_A_1"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RG-1501-02646"],"award-info":[{"award-number":["RG-1501-02646"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HD04612"],"award-info":[{"award-number":["HD04612"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007379","name":"Fondation pour l'Aide \u00e0 la Recherche sur la Scl\u00e9rose en Plaques","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007379","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12974-016-0626-3","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T19:47:31Z","timestamp":1467229651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage"],"prefix":"10.1186","volume":"13","author":[{"given":"Catalina","family":"Abad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavaani","family":"Jayaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurine","family":"Becquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Sue","family":"O\u2019Dorisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Waschek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yossan-Var","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,29]]},"reference":[{"key":"626_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1124\/pr.109.001370","volume":"61","author":"D Vaudry","year":"2009","unstructured":"Vaudry D, Falluel-Morel A, Bourgault S, Basille M, Burel D, Wurtz O, Fournier A, Chow BK, Hashimoto H, Galas L, Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20\u00a0years after the discovery. Pharmacol Rev. 2009;61:283\u2013357.","journal-title":"Pharmacol Rev"},{"key":"626_CR2","first-page":"221","volume":"50","author":"J Fahrenkrug","year":"2010","unstructured":"Fahrenkrug J. VIP and PACAP. Results Probl Cell Differ. 2010;50:221\u201334.","journal-title":"Results Probl Cell Differ"},{"key":"626_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1476-5381.2012.01871.x","volume":"166","author":"AJ Harmar","year":"2012","unstructured":"Harmar AJ, Fahrenkrug J, Gozes I, Laburthe M, May V, Pisegna JR, Vaudry D, Vaudry H, Waschek JA, Said SI. Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br J Pharmacol. 2012;166:4\u201317.","journal-title":"Br J Pharmacol"},{"key":"626_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1124\/pr.56.2.7","volume":"56","author":"M Delgado","year":"2004","unstructured":"Delgado M, Pozo D, Ganea D. The significance of vasoactive intestinal peptide in immunomodulation. Pharmacol Rev. 2004;56:249\u201390.","journal-title":"Pharmacol Rev"},{"key":"626_CR5","doi-asserted-by":"publisher","first-page":"31427","DOI":"10.1074\/jbc.273.47.31427","volume":"273","author":"M Delgado","year":"1998","unstructured":"Delgado M, Munoz-Elias EJ, Kan Y, Gozes I, Fridkin M, Brenneman DE, Gomariz RP, Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor alpha transcriptional activation by regulating nuclear factor-kB and cAMP response element-binding protein\/c-Jun. J Biol Chem. 1998;273:31427\u201336.","journal-title":"J Biol Chem"},{"key":"626_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0165-5728(96)00063-X","volume":"68","author":"M Delgado","year":"1996","unstructured":"Delgado M, Martinez C, Johnson MC, Gomariz RP, Ganea D. Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes. J Neuroimmunol. 1996;68:27\u201338.","journal-title":"J Neuroimmunol"},{"key":"626_CR7","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1189\/jlb.1203626","volume":"75","author":"M Delgado","year":"2004","unstructured":"Delgado M, Reduta A, Sharma V, Ganea D. VIP\/PACAP oppositely affects immature and mature dendritic cell expression of CD80\/CD86 and the stimulatory activity for CD4(+) T cells. J Leukoc Biol. 2004;75:1122\u201330.","journal-title":"J Leukoc Biol"},{"key":"626_CR8","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/S0167-4889(97)00104-3","volume":"1359","author":"D Pozo","year":"1997","unstructured":"Pozo D, Delgado M, Martinez C, Gomariz RP, Guerrero JM, Calvo JR. Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophages. Biochim Biophys Acta. 1997;1359:250\u201362.","journal-title":"Biochim Biophys Acta"},{"key":"626_CR9","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.4049\/jimmunol.162.4.2358","volume":"162","author":"M Delgado","year":"1999","unstructured":"Delgado M, Pozo D, Martinez C, Leceta J, Calvo JR, Ganea D, Gomariz RP. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies. J Immunol. 1999;162:2358\u201367.","journal-title":"J Immunol"},{"key":"626_CR10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/jlb.63.5.591","volume":"63","author":"C Martinez","year":"1998","unstructured":"Martinez C, Delgado M, Pozo D, Leceta J, Calvo JR, Ganea D, Gomariz RP. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages. J Leukoc Biol. 1998;63:591\u2013601.","journal-title":"J Leukoc Biol"},{"key":"626_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0165-5728(99)00023-5","volume":"96","author":"M Delgado","year":"1999","unstructured":"Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D. VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNgamma synthesis by T cells. J Neuroimmunol. 1999;96:167\u201381.","journal-title":"J Neuroimmunol"},{"key":"626_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.regpep.2006.04.021","volume":"137","author":"A Chorny","year":"2006","unstructured":"Chorny A, Gonzalez-Rey E, Varela N, Robledo G, Delgado M. Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions. Regul Pept. 2006;137:67\u201374.","journal-title":"Regul Pept"},{"key":"626_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S1471-4906(03)00069-3","volume":"24","author":"M Delgado","year":"2003","unstructured":"Delgado M. VIP: a very important peptide in T helper differentiation. Trends Immunol. 2003;24:221\u20134.","journal-title":"Trends Immunol"},{"key":"626_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0167-0115(02)00182-9","volume":"109","author":"JK Voice","year":"2002","unstructured":"Voice JK, Dorsam G, Chan RC, Grinninger C, Kong Y, Goetzl EJ. Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide. Regul Pept. 2002;109:199\u2013208.","journal-title":"Regul Pept"},{"key":"626_CR15","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.4049\/jimmunol.163.7.3629","volume":"163","author":"M Delgado","year":"1999","unstructured":"Delgado M, Leceta J, Gomariz RP, Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression. J Immunol. 1999;163:3629\u201335.","journal-title":"J Immunol"},{"key":"626_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1749-6632.2000.tb06952.x","volume":"921","author":"M Delgado","year":"2000","unstructured":"Delgado M, Leceta J, Sun W, Gomariz RP, Ganea D. VIP and PACAP induce shift to a Th2 response by upregulating B7.2 expression. Ann N Y Acad Sci. 2000;921:68\u201378.","journal-title":"Ann N Y Acad Sci"},{"key":"626_CR17","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1096\/fj.04-1548fje","volume":"18","author":"M Delgado","year":"2004","unstructured":"Delgado M, Gonzalez-Rey E, Ganea D. VIP\/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells. FASEB J. 2004;18:1453\u20135.","journal-title":"FASEB J"},{"key":"626_CR18","doi-asserted-by":"publisher","first-page":"5920","DOI":"10.4049\/jimmunol.177.9.5920","volume":"177","author":"D Fabricius","year":"2006","unstructured":"Fabricius D, O'Dorisio MS, Blackwell S, Jahrsdorfer B. Human plasmacytoid dendritic cell function: inhibition of IFN-alpha secretion and modulation of immune phenotype by vasoactive intestinal peptide. J Immunol. 2006;177:5920\u20137.","journal-title":"J Immunol"},{"key":"626_CR19","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1196\/annals.1317.077","volume":"1070","author":"V Sharma","year":"2006","unstructured":"Sharma V, Delgado M, Ganea D. VIP protects Th2 cells by downregulating granzyme B expression. Ann N Y Acad Sci. 2006;1070:540\u20134.","journal-title":"Ann N Y Acad Sci"},{"key":"626_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4049\/jimmunol.176.1.97","volume":"176","author":"V Sharma","year":"2006","unstructured":"Sharma V, Delgado M, Ganea D. Granzyme B, a new player in activation-induced cell death, is down-regulated by vasoactive intestinal peptide in Th2 but not Th1 effectors. J Immunol. 2006;176:97\u2013110.","journal-title":"J Immunol"},{"key":"626_CR21","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1096\/fj.02-0248fje","volume":"16","author":"M Delgado","year":"2002","unstructured":"Delgado M, Leceta J, Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide promote in vivo generation of memory Th2 cells. FASEB J. 2002;16:1844\u20136.","journal-title":"FASEB J"},{"key":"626_CR22","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1189\/jlb.0605299","volume":"78","author":"M Delgado","year":"2005","unstructured":"Delgado M, Chorny A, Gonzalez-Rey E, Ganea D. Vasoactive intestinal peptide generates CD4\u2009+\u2009CD25+ regulatory T cells in vivo. J Leukoc Biol. 2005;78:1327\u201338.","journal-title":"J Leukoc Biol"},{"key":"626_CR23","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1182\/blood-2005-11-4497","volume":"107","author":"E Gonzalez-Rey","year":"2006","unstructured":"Gonzalez-Rey E, Chorny A, Fernandez-Martin A, Ganea D, Delgado M. Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells. Blood. 2006;107:3632\u20138.","journal-title":"Blood"},{"key":"626_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.molmed.2007.04.003","volume":"13","author":"E Gonzalez-Rey","year":"2007","unstructured":"Gonzalez-Rey E, Delgado M. Vasoactive intestinal peptide and regulatory T-cell induction: a new mechanism and therapeutic potential for immune homeostasis. Trends Mol Med. 2007;13:241\u201351.","journal-title":"Trends Mol Med"},{"key":"626_CR25","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1053\/j.gastro.2006.10.023","volume":"131","author":"E Gonzalez-Rey","year":"2006","unstructured":"Gonzalez-Rey E, Delgado M. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide. Gastroenterology. 2006;131:1799\u2013811.","journal-title":"Gastroenterology"},{"key":"626_CR26","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/art.21652","volume":"54","author":"E Gonzalez-Rey","year":"2006","unstructured":"Gonzalez-Rey E, Fernandez-Martin A, Chorny A, Delgado M. Vasoactive intestinal peptide induces CD4+, CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis. Arthritis Rheum. 2006;54:864\u201376.","journal-title":"Arthritis Rheum"},{"key":"626_CR27","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/eji.200535430","volume":"36","author":"A Fernandez-Martin","year":"2006","unstructured":"Fernandez-Martin A, Gonzalez-Rey E, Chorny A, Ganea D, Delgado M. Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis. Eur J Immunol. 2006;36:318\u201326.","journal-title":"Eur J Immunol"},{"key":"626_CR28","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/87887","volume":"7","author":"M Delgado","year":"2001","unstructured":"Delgado M, Abad C, Martinez C, Leceta J, Gomariz RP. Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat Med. 2001;7:563\u20138.","journal-title":"Nat Med"},{"key":"626_CR29","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1053\/gast.2003.50141","volume":"124","author":"C Abad","year":"2003","unstructured":"Abad C, Martinez C, Juarranz MG, Arranz A, Leceta J, Delgado M, Gomariz RP. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn\u2019s disease. Gastroenterology. 2003;124:961\u201371.","journal-title":"Gastroenterology"},{"key":"626_CR30","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.2353\/ajpath.2006.051081","volume":"168","author":"E Gonzalez-Rey","year":"2006","unstructured":"Gonzalez-Rey E, Fernandez-Martin A, Chorny A, Martin J, Pozo D, Ganea D, Delgado M. Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis: down-regulation of inflammatory and autoimmune responses. Am J Pathol. 2006;168:1179\u201388.","journal-title":"Am J Pathol"},{"key":"626_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jaut.2013.06.008","volume":"45","author":"M Rangachari","year":"2013","unstructured":"Rangachari M, Kuchroo VK. Using EAE to better understand principles of immune function and autoimmune pathology. J Autoimmun. 2013;45:31\u20139.","journal-title":"J Autoimmun"},{"key":"626_CR32","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1474-4422(14)70305-9","volume":"14","author":"B Hemmer","year":"2015","unstructured":"Hemmer B, Kerschensteiner M, Korn T. Role of the innate and adaptive immune responses in the course of multiple sclerosis. Lancet Neurol. 2015;14:406\u201319.","journal-title":"Lancet Neurol"},{"key":"626_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.bbi.2014.09.020","volume":"44","author":"YV Tan","year":"2015","unstructured":"Tan YV, Abad C, Wang Y, Lopez R, Waschek JA. VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1\/Th17 and reduced Th2\/Treg responses. Brain Behav Immun. 2015;44:167\u201375.","journal-title":"Brain Behav Immun"},{"key":"626_CR34","doi-asserted-by":"publisher","first-page":"19555","DOI":"10.1073\/pnas.1007622107","volume":"107","author":"C Abad","year":"2010","unstructured":"Abad C, Tan YV, Lopez R, Nobuta H, Dong H, Phan P, Feng JM, Campagnoni AT, Waschek JA. Vasoactive intestinal peptide loss leads to impaired CNS parenchymal T-cell infiltration and resistance to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2010;107:19555\u201360.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"626_CR35","doi-asserted-by":"publisher","first-page":"e36922","DOI":"10.1371\/journal.pone.0036922","volume":"7","author":"C Abad","year":"2012","unstructured":"Abad C, Tan Y-V, Cheung-Lau G, Nobuta H, Waschek JA. VIP deficient mice exhibit resistance to lipopolysaccharide induced endotoxemia with an intrinsic defect in proinflammatory cellular responses. PLoS One. 2012;7:e36922.","journal-title":"PLoS One"},{"key":"626_CR36","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000364912","volume":"22","author":"C Abad","year":"2015","unstructured":"Abad C, Cheung-Lau G, Coute-Monvoisin A-C, Waschek JA. Vasoactive intestinal peptide-deficient mice exhibit reduced pathology in trinitrobenzene sulfonic acid-induced colitis. Neuroimmunomodulation. 2015;22:203\u201312.","journal-title":"Neuroimmunomodulation"},{"key":"626_CR37","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1097\/MPA.0b013e318214c783","volume":"40","author":"D Fabricius","year":"2011","unstructured":"Fabricius D, Karacay B, Shutt D, Leverich W, Schafer B, Takle E, Thedens D, Khanna G, Raikwar S, Yang B, et al. Characterization of intestinal and pancreatic dysfunction in VPAC1-null mutant mouse. Pancreas. 2011;40:861\u201371.","journal-title":"Pancreas"},{"key":"626_CR38","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1073\/pnas.0812257106","volume":"106","author":"YV Tan","year":"2009","unstructured":"Tan YV, Abad C, Lopez R, Dong H, Liu S, Lee A, Gomariz RP, Leceta J, Waschek JA. Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2009;106:2012\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"626_CR39","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/S0196-9781(97)00230-1","volume":"18","author":"P Gourlet","year":"1997","unstructured":"Gourlet P, De Neef P, Cnudde J, Waelbroeck M, Robberecht P. In vitro properties of a high affinity selective antagonist of the VIP1 receptor. Peptides. 1997;18:1555\u201360.","journal-title":"Peptides"},{"key":"626_CR40","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif). 2001;25:402\u20138.","journal-title":"Methods (San Diego, Calif)"},{"key":"626_CR41","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ana.21379","volume":"65","author":"P Kivisakk","year":"2009","unstructured":"Kivisakk P, Imitola J, Rasmussen S, Elyaman W, Zhu B, Ransohoff RM, Khoury SJ. Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis. Ann Neurol. 2009;65:457\u201369.","journal-title":"Ann Neurol"},{"key":"626_CR42","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1084\/jem.193.6.713","volume":"193","author":"DR Huang","year":"2001","unstructured":"Huang DR, Wang J, Kivisakk P, Rollins BJ, Ransohoff RM. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med. 2001;193:713\u201326.","journal-title":"J Exp Med"},{"key":"626_CR43","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1084\/jem.192.6.899","volume":"192","author":"BT Fife","year":"2000","unstructured":"Fife BT, Huffnagle GB, Kuziel WA, Karpus WJ. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J Exp Med. 2000;192:899\u2013905.","journal-title":"J Exp Med"},{"key":"626_CR44","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1002\/1521-4141(200011)30:11<3236::AID-IMMU3236>3.0.CO;2-L","volume":"30","author":"M Delgado","year":"2000","unstructured":"Delgado M, Gomariz RP, Martinez C, Abad C, Leceta J. Anti-inflammatory properties of the type 1 and type 2 vasoactive intestinal peptide receptors: role in lethal endotoxic shock. Eur J Immunol. 2000;30:3236\u201346.","journal-title":"Eur J Immunol"},{"key":"626_CR45","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.4049\/jimmunol.166.4.2522","volume":"166","author":"M Lara-Marquez","year":"2001","unstructured":"Lara-Marquez M, O'Dorisio M, O'Dorisio T, Shah M, Karacay B. Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells. J Immunol. 2001;166:2522\u201330.","journal-title":"J Immunol"},{"key":"626_CR46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1479-5876-11-117","volume":"11","author":"A Storka","year":"2013","unstructured":"Storka A, Burian B, Fuhrlinger G, Clive B, Sun T, Crevenna R, Gsur A, Mosgoller W, Wolzt M. VPAC1 receptor expression in peripheral blood mononuclear cells in a human endotoxemia model. J Transl Med. 2013;11:117.","journal-title":"J Transl Med"},{"key":"626_CR47","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jim.2011.10.009","volume":"376","author":"RJ Hermann","year":"2012","unstructured":"Hermann RJ, Van der Steen T, Vomhof-Dekrey EE, Al-Badrani S, Wanjara SB, Failing JJ, Haring JS, Dorsam GP. Characterization and use of a rabbit-anti-mouse VPAC1 antibody by flow cytometry. J Immunol Methods. 2012;376:20\u201331.","journal-title":"J Immunol Methods"},{"key":"626_CR48","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.bbi.2008.04.005","volume":"22","author":"EE Vomhof-DeKrey","year":"2008","unstructured":"Vomhof-DeKrey EE, Hermann RJ, Palmer MF, Benton KD, Sandy AR, Dorsam ST, Dorsam GP. TCR signaling and environment affect vasoactive intestinal peptide receptor-1 (VPAC-1) expression in primary mouse CD4 T cells. Brain Behav Immun. 2008;22:1032\u201340.","journal-title":"Brain Behav Immun"},{"key":"626_CR49","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.bbi.2008.04.006","volume":"22","author":"EE Vomhof-DeKrey","year":"2008","unstructured":"Vomhof-DeKrey EE, Dorsam GP. Stimulatory and suppressive signal transduction regulates vasoactive intestinal peptide receptor-1 (VPAC-1) in primary mouse CD4 T cells. Brain Behav Immun. 2008;22:1024\u201331.","journal-title":"Brain Behav Immun"},{"key":"626_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012067","volume":"5","author":"E Cocco","year":"2010","unstructured":"Cocco E, Paladini F, Macino G, Fulci V, Fiorillo MT, Sorrentino R. The expression of vasoactive intestinal peptide receptor 1 is negatively modulated by microRNA 525-5p. PLoS One. 2010;5, e12067.","journal-title":"PLoS One"},{"key":"626_CR51","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1111\/j.1582-4934.2008.00662.x","volume":"13","author":"JL Herrera","year":"2009","unstructured":"Herrera JL, Gonzalez-Rey E, Fernandez-Montesinos R, Quintana FJ, Najmanovich R, Pozo D. Toll-like receptor stimulation differentially regulates vasoactive intestinal peptide type 2 receptor in macrophages. J Cell Mol Med. 2009;13:3209\u201317.","journal-title":"J Cell Mol Med"},{"key":"626_CR52","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1600-065X.2012.01133.x","volume":"248","author":"N Kawakami","year":"2012","unstructured":"Kawakami N, Bartholomaus I, Pesic M, Mues M. An autoimmunity odyssey: how autoreactive T cells infiltrate into the CNS. Immunol Rev. 2012;248:140\u201355.","journal-title":"Immunol Rev"},{"key":"626_CR53","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.4049\/jimmunol.153.4.1762","volume":"153","author":"JA Johnston","year":"1994","unstructured":"Johnston JA, Taub DD, Lloyd AR, Conlon K, Oppenheim JJ, Kevlin DJ. Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide. J Immunol. 1994;153:1762\u20138.","journal-title":"J Immunol"},{"key":"626_CR54","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4049\/jimmunol.156.1.160","volume":"156","author":"M Xia","year":"1996","unstructured":"Xia M, Leppert D, Hauser SL, Sreedharan SP, Nelson PJ, Krensky AM, Goetzl EJ. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J Immunol. 1996;156:160\u20137.","journal-title":"J Immunol"},{"key":"626_CR55","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0165-5728(98)00043-5","volume":"87","author":"P Schratzberger","year":"1998","unstructured":"Schratzberger P, Geiseler A, Dunzendorfer S, Reinisch N, Kahler CM, Wiedermann CJ. Similar involvement of VIP receptor type I and type II in lymphocyte chemotaxis. J Neuroimmunol. 1998;87:73\u201381.","journal-title":"J Neuroimmunol"},{"key":"626_CR56","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.molimm.2010.01.003","volume":"47","author":"ST Dorsam","year":"2010","unstructured":"Dorsam ST, Vomhof-Dekrey E, Hermann RJ, Haring JS, Van der Steen T, Wilkerson E, Boskovic G, Denvir J, Dementieva Y, Primerano D, Dorsam GP. Identification of the early VIP-regulated transcriptome and its associated, interactome in resting and activated murine CD4 T cells. Mol Immunol. 2010;47:1181\u201394.","journal-title":"Mol Immunol"},{"key":"626_CR57","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.peptides.2013.01.007","volume":"42","author":"J Yang","year":"2013","unstructured":"Yang J, Shi QD, Song TB, Feng GF, Zang WJ, Zong CH, Chang L. Vasoactive intestinal peptide increases VEGF expression to promote proliferation of brain vascular endothelial cells via the cAMP\/PKA pathway after ischemic insult in vitro. Peptides. 2013;42:105\u201311.","journal-title":"Peptides"},{"key":"626_CR58","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1016\/j.peptides.2010.08.013","volume":"31","author":"A Castorina","year":"2010","unstructured":"Castorina A, Giunta S, Mazzone V, Cardile V, D'Agata V. Effects of PACAP and VIP on hyperglycemia-induced proliferation in murine microvascular endothelial cells. Peptides. 2010;31:2276\u201383.","journal-title":"Peptides"},{"key":"626_CR59","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/cne.20231","volume":"476","author":"KM Joo","year":"2004","unstructured":"Joo KM, Chung YH, Kim MK, Nam RH, Lee BL, Lee KH, Cha CI. Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain. J Comp Neurol. 2004;476:388\u2013413.","journal-title":"J Comp Neurol"},{"key":"626_CR60","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S0006-291X(02)00283-8","volume":"293","author":"M Delgado","year":"2002","unstructured":"Delgado M. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the MEKK1\/MEK4\/JNK signaling pathway in endotoxin-activated microglia. Biochem Biophys Res Commun. 2002;293:771\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"626_CR61","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cell.2012.01.022","volume":"148","author":"Y Arima","year":"2012","unstructured":"Arima Y, Harada M, Kamimura D, Park JH, Kawano F, Yull FE, Kawamoto T, Iwakura Y, Betz UA, Marquez G, et al. Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier. Cell. 2012;148:447\u201357.","journal-title":"Cell"},{"key":"626_CR62","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0165-5728(98)00018-6","volume":"85","author":"C Martinez","year":"1998","unstructured":"Martinez C, Delgado M, Pozo D, Leceta J, Calvo JR, Ganea D, Gomariz RP. VIP and PACAP enhance IL-6 release and mRNA levels in resting peritoneal macrophages: in vitro and in vivo studies. J Neuroimmunol. 1998;85:155\u201367.","journal-title":"J Neuroimmunol"},{"key":"626_CR63","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/ni.1716","volume":"10","author":"A Reboldi","year":"2009","unstructured":"Reboldi A, Coisne C, Baumjohann D, Benvenuto F, Bottinelli D, Lira S, Uccelli A, Lanzavecchia A, Engelhardt B, Sallusto F. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol. 2009;10:514\u201323.","journal-title":"Nat Immunol"},{"issue":"Suppl","key":"626_CR64","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1291\/hypres.26.S61","volume":"26","author":"B Kis","year":"2003","unstructured":"Kis B, Abraham CS, Deli MA, Kobayashi H, Niwa M, Yamashita H, Busija DW, Ueta Y. Adrenomedullin, an autocrine mediator of blood-brain barrier function. Hypertens Res. 2003;26(Suppl):S61\u201370.","journal-title":"Hypertens Res"},{"key":"626_CR65","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.peptides.2005.07.009","volume":"27","author":"B Kis","year":"2006","unstructured":"Kis B, Chen L, Ueta Y, Busija DW. Autocrine peptide mediators of cerebral endothelial cells and their role in the regulation of blood-brain barrier. Peptides. 2006;27:211\u201322.","journal-title":"Peptides"},{"key":"626_CR66","doi-asserted-by":"publisher","first-page":"792428","DOI":"10.1155\/2008\/792428","volume":"2008","author":"DR Staines","year":"2008","unstructured":"Staines DR, Brenu EW, Marshall-Gradisnik S. Postulated role of vasoactive neuropeptide-related immunopathology of the blood brain barrier and Virchow-Robin spaces in the aetiology of neurological-related conditions. Mediators Inflamm. 2008;2008:792428.","journal-title":"Mediators Inflamm"},{"key":"626_CR67","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1111\/j.1468-2982.2006.01149.x","volume":"26","author":"JM Hansen","year":"2006","unstructured":"Hansen JM, Sitarz J, Birk S, Rahmann AM, Oturai PS, Fahrenkrug J, Olesen J, Ashina M. Vasoactive intestinal polypeptide evokes only a minimal headache in healthy volunteers. Cephalalgia. 2006;26:992\u20131003.","journal-title":"Cephalalgia"},{"key":"626_CR68","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/brain\/awn307","volume":"132","author":"HW Schytz","year":"2009","unstructured":"Schytz HW, Birk S, Wienecke T, Kruuse C, Olesen J, Ashina M. PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain. 2009;132:16\u201325.","journal-title":"Brain"},{"key":"626_CR69","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cellimm.2011.01.001","volume":"267","author":"M Yadav","year":"2011","unstructured":"Yadav M, Huang MC, Goetzl EJ. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis. Cell Immunol. 2011;267:124\u201332.","journal-title":"Cell Immunol"},{"key":"626_CR70","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0165-5728(93)90286-8","volume":"47","author":"D Maimone","year":"1993","unstructured":"Maimone D, Cioni C, Rosa S, Macchia G, Aloisi F, Annunziata P. Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: synergism with IL-1 beta and TNF alpha. J Neuroimmunol. 1993;47:73\u201381.","journal-title":"J Neuroimmunol"},{"key":"626_CR71","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/S0301-472X(02)00875-5","volume":"30","author":"P Rameshwar","year":"2002","unstructured":"Rameshwar P, Gascon P, Oh HS, Denny TN, Zhu G, Ganea D. Vasoactive intestinal peptide (VIP) inhibits the proliferation of bone marrow progenitors through the VPAC1 receptor. Exp Hematol. 2002;30:1001\u20139.","journal-title":"Exp Hematol"},{"key":"626_CR72","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.4049\/jimmunol.1300384","volume":"191","author":"L Souza-Moreira","year":"2013","unstructured":"Souza-Moreira L, Morell M, Delgado-Maroto V, Pedreno M, Martinez-Escudero L, Caro M, O'Valle F, Luque R, Gallo M, de Lecea L, et al. Paradoxical effect of cortistatin treatment and its deficiency on experimental autoimmune encephalomyelitis. J Immunol. 2013;191:2144\u201354.","journal-title":"J Immunol"},{"key":"626_CR73","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000140676","volume":"88","author":"DH Loh","year":"2008","unstructured":"Loh DH, Abad C, Colwell CS, Waschek JA. Vasoactive intestinal peptide is critical for circadian regulation of glucocorticoids. Neuroendocrinology. 2008;88:246\u201355.","journal-title":"Neuroendocrinology"}],"updated-by":[{"DOI":"10.1186\/s12974-017-0927-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T00:00:00Z","timestamp":1501804800000}}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-016-0626-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-016-0626-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-016-0626-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-016-0626-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:48:45Z","timestamp":1718671725000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-016-0626-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,29]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["626"],"URL":"https:\/\/doi.org\/10.1186\/s12974-016-0626-3","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12974-017-0927-1","asserted-by":"object"}]},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,29]]},"assertion":[{"value":"4 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2017","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An erratum to this article has been published.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"169"}}